Fresenius
Update in progressFRE.DE (XETRA)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Care Facilities
Fresenius SE & Co. KGaA is a global health care company serving chronically ill patients in North America, Europe, Asia-Pacific, Latin America and Africa. It operates through two segments: Fresenius Kabi, offering biopharmaceuticals, clinical nutrition, IV meds and fluids, biosimilars, nutrition products, and MedTech devices; and Fresenius Helios, which runs hospitals, outpatient centers and diagnostics. Founded 1912, based in Bad Homburg, Germany.
Company score
- Sentiment
- 0.11
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.10
- Governance
- 0.06
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.05
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.08
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketXETRA (GER)
- LocationGermany
- CEOMr. Michael Sen
- Founded1912
- Employees178,486
- Websitewww.fresenius.com
Identifiers
- ISINDE0005785604